The medtech firm, which previously forecast a $200 million tariff impact for 2025, also raised its earnings outlook, citing ...

Stryker’s financials revealed total sales of $3.7bn in its medical surgery and neurotechnology business unit, up 17.3% on Q2 ...

Medical technology company Stryker (NYSE:SYK) reported Q2 CY2025 results , with sales up 11.1% year on year to $6.02 billion.

Stryker reached a key milestone with its Mako robotics, Jason Beach, vice president of finance and investor relations, said in a July 31 earnings call. During the second quarter Stryker reached 2 ...

Stryker saw year-over-year revenue growth in the second quarter of 2025, according to financial results posted July 31. Six things to know: 1. Quarterly revenue reached $6 billion, an 11.1% increase ...

Insights from analysts' 12-month price targets are revealed, presenting an average target of $429.5, a high estimate of $455.00, and a low estimate of $400.00. Marking an increase of 3.18%, the ...

Stryker sells two product lines, OP-1 and Calstrux, for reconstructing bones damaged by surgery or injury. The products actively recruit new blood supply, promote bone growth, and fill voids in bones.

This was the stock's fifth consecutive day of losses.

The Stryker, produced by General Dynamics Land Systems, comes in 10 variants. The infantry carrier variant can shuttle a full squad of seven Soldiers, in addition to a vehicle commander, driver ...